What is CE&IC?
Established in 1984, CE&IC operates as a full-service cGMP engineering and design firm, catering exclusively to the pharmaceutical and biotechnology industries. The company provides a comprehensive suite of services, encompassing project design, expert consulting, and multi-disciplinary engineering. CE&IC is distinguished by its proficiency in developing compliant processes and facilities, aiming for both operational efficiency and cost-effectiveness. Its sustained success has fostered enduring partnerships with numerous industry leaders, reflecting a deep understanding of client needs and regulatory landscapes.
How much funding has CE&IC raised?
CE&IC has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in CE&IC
PPP
Public-Private Partnership
What's next for CE&IC?
The recent large-scale, late-stage funding indicates CE&IC is poised for significant expansion and strategic development. This capital injection is likely to fuel advancements in its service offerings, potentially enabling the firm to take on larger, more complex projects, enhance its technological capabilities, or broaden its market reach within the highly regulated pharmaceutical and biotech sectors. The strategic nature of this investment suggests a focus on long-term growth and strengthening its competitive advantage.
See full CE&IC company page
